These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework? Basile EM; Lorell BH Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031 [No Abstract] [Full Text] [Related]
23. What is the Medical Device and Lab Product Problem Reporting Program? Moore R Pharm Times; 1982 Nov; 48(11):53-7. PubMed ID: 10257641 [No Abstract] [Full Text] [Related]
24. Myths and realities in medical packaging. Pilchik R Med Device Technol; 2003 Mar; 14(2):16-7. PubMed ID: 12698692 [TBL] [Abstract][Full Text] [Related]
25. Medical device reports raise and red flag. Miles F; Miles JF Provider; 1997 Jan; 23(1):53, 55-6. PubMed ID: 10166155 [No Abstract] [Full Text] [Related]
26. Medical devices; medical device reporting. Direct final rule. Food and Drug Administration, HHS Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310 [TBL] [Abstract][Full Text] [Related]
27. FDA announces MedWatch: a new reporting program for health professionals. Hopkinson SE AANA J; 1993 Aug; 61(4):373-8. PubMed ID: 8379285 [No Abstract] [Full Text] [Related]
28. MedWatch: the FDA medical products reporting program. Rheinstein PH Am Fam Physician; 1993 Sep; 48(4):636-8. PubMed ID: 8379493 [No Abstract] [Full Text] [Related]
29. Charge! FDA recommendations for maintaining defibrillator readiness. White RD; Chesemore KF JEMS; 1992 Apr; 17(4):70-2, 82. PubMed ID: 10117528 [No Abstract] [Full Text] [Related]
30. Agencies seek discussion about reuse. No silence, please! Mater Manag Health Care; 1997 May; 6(5):38. PubMed ID: 10167494 [No Abstract] [Full Text] [Related]
31. Clinically available intracorporeal left ventricular assist devices. McCarthy PM; Hoercher K Prog Cardiovasc Dis; 2000; 43(1):37-46. PubMed ID: 10935556 [TBL] [Abstract][Full Text] [Related]
32. Postmarket surveillance. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947 [TBL] [Abstract][Full Text] [Related]
33. Medical devices; device tracking. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Feb; 67(27):5943-52. PubMed ID: 11838471 [TBL] [Abstract][Full Text] [Related]
34. FDA works to reduce preventable medical device injuries. Rados C FDA Consum; 2003; 37(4):29-33. PubMed ID: 12971346 [No Abstract] [Full Text] [Related]
35. US Food and Drug Administration: adverse event reporting. Graham AA CRNA; 1998 Nov; 9(4):135-8. PubMed ID: 9866488 [TBL] [Abstract][Full Text] [Related]
36. Between physician and patient: the technological link. Manners S Can Doct; 1984 Nov; 50(11):46-9. PubMed ID: 10268919 [No Abstract] [Full Text] [Related]
38. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule. Food and Drug Administration, HHS Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859 [TBL] [Abstract][Full Text] [Related]
39. Bedrail entrapment and a paralyzed industry. Cote V Director; 2005; 13(2):96, 98, 100. PubMed ID: 15952479 [No Abstract] [Full Text] [Related]